High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II

Int J Mol Sci. 2020 Jul 30;21(15):5449. doi: 10.3390/ijms21155449.

Abstract

We recently developed a blood-brain barrier (BBB)-penetrating enzyme transport vehicle (ETV) fused to the lysosomal enzyme iduronate 2-sulfatase (ETV:IDS) and demonstrated its ability to reduce glycosaminoglycan (GAG) accumulation in the brains of a mouse model of mucopolysaccharidosis (MPS) II. To accurately quantify GAGs, we developed a plate-based high-throughput enzymatic digestion assay coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to simultaneously measure heparan sulfate and dermatan sulfate derived disaccharides in tissue, cerebrospinal fluid (CSF) and individual cell populations isolated from mouse brain. The method offers ultra-high sensitivity enabling quantitation of specific GAG species in as low as 100,000 isolated neurons and a low volume of CSF. With an LOD at 3 ng/mL and LLOQs at 5-10 ng/mL, this method is at least five times more sensitive than previously reported approaches. Our analysis demonstrated that the accumulation of CSF and brain GAGs are in good correlation, supporting the potential use of CSF GAGs as a surrogate biomarker for brain GAGs. The bioanalytical method was qualified through the generation of standard curves in matrix for preclinical studies of CSF, demonstrating the feasibility of this assay for evaluating therapeutic effects of ETV:IDS in future studies and applications in a wide variety of MPS disorders.

Keywords: cerebrospinal fluid; dermatan sulfate; glycosaminoglycans; heparan sulfate; iduronate 2-sulfatase; liquid chromatography-tandem mass spectrometry; mucopolysaccharidosis.

MeSH terms

  • Animals
  • Biomarkers / metabolism*
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Brain / metabolism
  • Brain / pathology
  • Chromatography, Liquid
  • Dermatan Sulfate / pharmacology
  • Disaccharides / chemistry
  • Disease Models, Animal
  • Glycosaminoglycans / genetics
  • Glycosaminoglycans / isolation & purification*
  • Glycosaminoglycans / metabolism
  • Heparitin Sulfate / pharmacology
  • Humans
  • Iduronate Sulfatase / genetics*
  • Iduronate Sulfatase / metabolism
  • Mice
  • Mucopolysaccharidosis II / diagnosis*
  • Mucopolysaccharidosis II / genetics
  • Mucopolysaccharidosis II / pathology
  • Tandem Mass Spectrometry

Substances

  • Biomarkers
  • Disaccharides
  • Glycosaminoglycans
  • Dermatan Sulfate
  • Heparitin Sulfate
  • Iduronate Sulfatase